Mexico’s health ministry on Tuesday published rules to regulate the use of medicinal cannabis, a major step in a broader reform to create the world’s largest legal cannabis market in the Latin American country.
The new regulation, signed off on by Mexican President Andres Manuel Lopez Obrador, will now allow pharmaceutical companies to begin doing medical research on cannabis products.
The new medicinal rules state companies that wish to carry out research have to obtain permission from the Mexican health regulator, COFEPRIS, and this research has to be done in strictly controlled and independent laboratories.
Foreign marijuana companies from Canada and the United States have been looking at Mexico with interest. Many had delayed making investment decisions due to policy uncertainty and were waiting for the final regulation to be published.
Mexico’s lawmakers are also in the final stages of legalising the recreational use of marijuana, with the bill expected to pass in the next period of Congress.
The regulation comes several years after Mexico’s Supreme Court ruled that lawmakers must legalise the use of cannabis.
The legislation marks a major shift in a country bedevilled for years by violence between feuding drug cartels, which have long made millions of dollars growing marijuana illegally and smuggling it into the US.